Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/91682
PIRA download icon_1.1View/Download Full Text
Title: miR-320a in serum exosomes promotes myocardial fibroblast proliferation via regulating the PIK3CA/Akt/mTOR signaling pathway in HEH2 cells
Authors: Wang, QG
Cheng, BCY 
He, YZ
Li, LJ
Ling, Y
Luo, G
Wang, L
Liang, S
Zhang, Y
Issue Date: Aug-2021
Source: Experimental and therapeutic medicine, Aug. 2021, v. 22, no. 2, 873
Abstract: MicroRNAs (miRNAs/miRs) serve an important role in the pathogenesis of chronic heart failure (CHF). A number of reports have illustrated the regulatory effect of serum exosomal miRNA on myocardial fibrosis. The present study aimed to investigate the expression of miR-320a in serum exosomes, as well as the effect of miR-320a on myocardial fibroblast proliferation. Serum exosome samples from 10 patients with CHF and 5 healthy volunteers were obtained and characterized. mRNA and protein expression levels were measured via reverse transcription-quantitative PCR and western blotting, respectively. The content of soluble growth stimulation expressed gene 2 (sST2) was determined via ELISA. HEH2 cell viability and apoptosis were detected by performing MTT assays and flow cytometry, respectively. The results demonstrated that serum miR-320a expression levels and sST2 content were significantly increased in patients with CHF compared with healthy controls, and the expression of serum miR-320a was significantly correlated with clinical CHF indexes. miR-320a expression levels were significantly increased in exosomes isolated from patients with CHF compared with those isolated from healthy controls. Phosphoinositide-3-kinase catalytic alpha polypeptide gene (PIK3CA) expression levels and sST2 content were increased in HEH2 cells following transfection with miR-320a mimics compared with NC-mimic, whereas miR-320a inhibitor displayed contrasting effects by reduced the cell viability and apoptosis in myocardial fibroblasts compared with the NC-inhibitor group. The protein expression levels of collagen I, collagen III, alpha-smooth muscle actin, phosphorylated (p)-mTOR (ser 2448)/mTOR, p-Akt (ser 473)/Akt, p-Akt (thr 308)/Akt and PIK3CA were significantly increased in miR-320a mimic-transfected HEH2 cells compared with the NC-mimics groups. By contrast, miR-320a inhibitor notably downregulated the expression levels of these proteins compared with the NC-inhibitor group. Collectively, the results of the present study demonstrated that miR-320a promoted myocardial fibroblast proliferation via regulating the PIK3CA/Akt/mTOR signaling pathway in HEH2 cells, suggesting that serum exosomal miR-320a may serve as a potential biomarker for the diagnosis of CHF.
Keywords: CHF
Exosome
HEH2 cells
Myocardial fibrosis
PIK3CA
Akt
MTOR signaling pathway
Publisher: Spandidos Publications
Journal: Experimental and therapeutic medicine 
ISSN: 1792-0981
EISSN: 1792-1015
DOI: 10.3892/etm.2021.10305
Rights: © Wang et al.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
The following publication Wang, Q. G., Cheng, B. C. Y., He, Y. Z., Li, L. J., Ling, Y., Luo, G., ... & Zhang, Y. (2021). miR‑320a in serum exosomes promotes myocardial fibroblast proliferation via regulating the PIK3CA/Akt/mTOR signaling pathway in HEH2 cells. Experimental and Therapeutic Medicine, 22(2), 1-14 is available at https://doi.org/10.3892/etm.2021.10305
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
Wang_miR‑320a_serum_exosomes.pdf3.82 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

75
Last Week
0
Last month
Citations as of Mar 24, 2024

Downloads

32
Citations as of Mar 24, 2024

WEB OF SCIENCETM
Citations

9
Citations as of Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.